Weekly Digest – February 2025 Weekly Digest – February 2025 31 Jan 2025: Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU The FDA approved a label expansion for […]